Interview with Chairman and managing director, Biocon Praveen Bose | Bengaluru May 1, 2015 Last Updated at 00:37 IST Biopharma major Biocon has reported a good set of numbers. Kiran Mazumdar-Shaw, chairman and managing director, explains the strategy for the ... Business Standard, 4 days ago
Biocon will focus on niche areas to reach its goal of becoming a billion-dollar player by 2018, Kiran Mazumdar-Shaw, chairperson and MD, Biocon, indicated in a conference call with the media on Thursday after announcing the company's fourth quarter ...Business Today India, 5 days ago Rationalising products to become specialised player: Biocon Money Control, 5 days ago
The executive council of the Association of Biotechnology Led Enterprises has elected Dr Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon, as its first non-executive chairman in an honorary capacity. Incidentally, Shaw also chairs ...Hindu Business Line, 4 weeks ago Kiran Mazumdar Shaw elected 1st non-executive chairman of ABLE ZeeNews.com, 4 weeks ago Kiran Mazumdar Shaw Elected As Non-executive Chairman of ABLE EHealth Magazine, 4 weeks ago Kiran Mazumdar Shaw elected as first non-executive chairman of ABLE, new EC formed PharmaBiz, 4 weeks ago
Is India Inc's new-found enthusiasm to have women board members a reflection of changing mindsets or mere tokenism?
Not just ticking the gender box By Kiran Mazumdar Shaw More than 250 companies appointed women directors on Wednesday to meet the Securities and Exchange Board of India's (Sebi) deadline to have at least one woman director on their boards by March ...Economic Times, 1 month ago Poke me: Is India Inc's new-found enthusiasm to have women board members a reflection of changing mindsets or mere tokenism? Economic Times, 1 month ago
Kiran Mazumdar Shaw, Chairperson and MD, Biocon also said that Syngene has good growth prospects and sound business plan and has a baseline valuation of Rs 3,800 crore.Money Control, 1 month ago Biocon Press Release on Q4 & FY 15 Results APN News, 5 days ago Biocon top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore Businessworld India, 5 days ago Syngene International to enter capital market with equity issue of 22 mn shares PharmaBiz, 6 days ago
The company will give out the details of amount that will be raised after getting approval from SEBI and Foreign Investment Promotion Board. Biocon's subsidiary company, Syngene International filed a Draft Red Herring Prospectus with the Securities and ...India Infoline, 1 week ago IPO of Syngene should be possible by July: Kiran Mazumdar Shaw India Infoline, 1 week ago
Six Indians, including State Bank of India chairman Arundhati Bhattacharyya and Biocon founder Kiran Mazumdar Shaw, figure in the Forbes's 2015 list of Asia's 50 Power Businesswomen showcasing a year of accomplishments by the region's female entrepreneurs and ...SME Times, 2 months ago Six Indians in Forbes 50 Asian power businesswomen list Prokerala, 2 months ago Forbes presents the richest women in India India Today, 1 month ago International Women's Day: India's super 6 achievers Jagran Post, 1 month ago
Biocon CEO Kiran Mazumdar-Shaw Indian biotech giant Biocon is planning to take Syngene, its in-house CRO, public in an IPO on the local exchange. As Business Standard reports, Biocon has filed to offer 22 million shares of Syngene, an 11% stake, ...Fierce CRO, 1 week ago Biocon's Syngene to build a plant in India FiercePharmaManufacturing, 1 month ago
SBS HINDI EXCLUSIVE WITH THE ONE AND ONLY KIRAN MAZUMDAR SHAW. One of India's most well known business tycoons, Kiran Mazumdar Shaw spoke exclusively toSpecial Broadcasting Service, 1 month ago Hundreds walk for Prabha despite bad weather Special Broadcasting Service, 1 month ago MEET RAMAN BHALLA THE LIBERAL CANDIDATE FROM BLACKTOWN Special Broadcasting Service, 1 month ago
Biocon, a Rs. 3,050 crore plus leading innovation-led bio-pharmaceutical company, has posted satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on ...PharmaBiz, 1 day ago Biocon's net increases by 78% Smart Investor, 4 days ago Biocon Q4 profit up 20% on Syngene stake sale Hindu Business Line, 5 days ago Marico Q4 profit up 24% to Rs 110 crore NewsR.in, 5 days ago
More from: , Financial Express...and 5 other sources
on your WebpageAdd Widget >Get your members hooked!